GW Pharmaceuticals PLC ADR

Q3 2014 vs. Q4 2017 13F Holders

Period
Q3 2014
Q4 2017
Num holders
98
232
Total reported value, excl. options
$650 M
$3.03 B
Total shares, excl. options
8,038,799
22,953,502
Manager Q3 2014
Shares
Q4 2017
Shares
Diff Chg %